Biotexia has introduced its new brand identity as it prepares to showcase its clinically supported ingredient portfolio at Vitafoods Europe (5th-7th May in Barcelona).
Biotexia is the new name for three health and nutrition businesses within ABF Ingredients that have merged. The companies previously operated as ABbiotek Health, Fytexia and Anzchem, each contributing unique expertise.
ABbiotek Health brings extensive experience in biotics that support the microbiome, including ABBC1, and in degrading histamine through its adiDAO enzyme. Fytexia offers leading capabilities in clinically supported polyphenols and peptides, with products like Promunel, Sinetrol® and DNF 10 in high demand. Anzchem contributes as a trusted legacy in fish oil lipids, deep knowledge of the APAC region, and a strong footprint in Australia and New Zealand.
As a unified brand, Biotexia delivers natural, science‑backed ingredients across four key areas: metabolic, immune and digestive health, while also innovating to support healthy ageing and vitality. The merger and new name launch are part of a strategy for growth in supplements markets.
Laurent Hubert, CEO of Biotexia, said: “The primary reason for the creation of Biotexia was to bring together our expertise to serve our customers at a time when the supplements industry is undergoing exciting shifts. Each of our three former businesses offered something valuable, and by bringing them together we will be able to innovate and share our scientific expertise more effectively. Moving forward as Biotexia, our goal is to expand and play an active part in the continuing evolution of the global wellness market.”
After many years of attending Vitafoods Europe as separate businesses, Biotexia will make its debut as a unified brand at Stand 3B6. As part of the Vitafoods education programme, Biotexia will sponsor the Weight Management Spotlight on 7 May, featuring insights on flagship ingredients DNF 10, a peptide studied for its role in appetite regulation, and Sinetrol, a natural citrus polyphenol complex researched for its ability to increase resting energy expenditure and promote lipolysis. The company will also present a dedicated session on 6 May in the Nutraceutical Theatre, exploring the science behind the functional enzyme DAO and showcasing adiDAO, a diamine oxidase enzyme developed to support the metabolism of dietary histamine in the gastrointestinal tract.
About Biotexia
Biotexia accelerates the development of consumer-focused nutraceutical solutions by delivering robust, clinically proven bioactives supported by complete technical and scientific dossiers. Formed from the combined expertise of ABbiotek Health, Fytexia and Anzchem, we help our partners move from concept to market-ready formulations faster and more confidently.
Driven by a passion for innovation and scientific rigor, we create bioactives that consumers trust, empowering our customers to launch differentiated, compliant products that improve health and longevity.
